[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354092-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-354092-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","next-generation-sequencing-identifies-novel-gene-alterations-with-potential-prognostic-relevance-in-pediatric-cancer-a-single-center-study","Next generation sequencing identifies novel gene alterations with potential prognostic relevance in pediatric cancer - a single-center study","","Background: Next generation sequencing (NGS) advances precision oncology. Pediatric cancer genomics, especially among Asian populations, has received less attention. Methods: Targeted NGS was used to screen gene alteration profiles in 99 pediatric cancer patients and results were compared with Western cohorts, with analyses linking genes to clinical characteristics. Results: KMT2D (18.2%), TP53 (11.1%), and DICER1 (9.1%) were most frequently altered. KMT2D was higher than Western cohorts; P/LP germline mutations were found in 3.5%. Conclusions: Findings refine the genomic landscape of Chinese pediatric cancer and support further validation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/next-generation-sequencing-identifies-novel-gene-alterations-with-potential-prognostic-relevance-in-pediatric-cancer-a-single-center-study/354092/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/next-generation-sequencing-identifies-novel-gene-alterations-with-potential-prognostic-relevance-in-pediatric-cancer-a-single-center-study/354092.png","ImageObject",300,407,{"name":42,"@type":43},"นรินทร์","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What method was used to detect gene alterations in this study?","Question",{"text":63,"@type":64},"Targeted next generation sequencing (NGS) was used to screen gene alteration profiles in 99 pediatric cancer patients.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which genes were most frequently mutated in the cohort?",{"text":68,"@type":64},"KMT2D was the most frequently mutated gene (18.2%), followed by TP53 (11.1%) and DICER1 (9.1%).",{"name":70,"@type":61,"acceptedAnswer":71},"What prognostic associations were reported for neuroblastoma?",{"text":72,"@type":64},"For intermediate-/high-risk neuroblastoma patients, MYCN amplification was associated with disease progression during induction chemotherapy, and gene alterations in the MAPK pathway were linked to poor survival.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},354092,1790193874,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":113,"preview_page_count":33,"preview_urls":146},2336475104957,"https://ap-avatar.wpscdn.com/avatar/22000c4c6bd8a5076e1?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787554080175789136","The Oncologist, 2026, 31, oyag147  \n[https://doi.org/10.1093/oncolo/oyag147](https://doi.org/10.1093/oncolo/oyag147)  \n[Published: 20 April 2026](Published: 20 April 2026)  \nOriginal Article  \nNext generation sequencing identifies novel gene alterations with potential prognostic relevance in pediatric cancer: a single-center study  \nYuhan Ma1,†, Mingwei Su2,†, Xiaoshan Liu1,†, Wenxia Wang1, Yu Wu3, Zhixuan Wang1, Xiaomin Peng1, Xilin Xiong1, Jiaying Lei1, Yang Li*,1,   \n1 Pediatric Hematology/Oncology, Children’s Medical Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China 2 Department of Head Neck and Thyroid Surgery, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, 450008, Zhengzhou, China  \n3 Department of Pediatric Intensive Care Unit, Shenzhen Children’s Hospital, 518026, Shenzhen, China †These authors should be considered joint first author.  \n*Corresponding author: Yang Li, Pediatric Hematology/Oncology, Children’s Medical Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, No. 107, Yanjiang West Road, Yuexiu District, Guangzhou, 510120, [China. Email:](China. Email: drliyang@126.com)[ drliyang@126.com](China. Email: drliyang@126.com).  \nAbstract  \nBackground: Next generation sequencing (NGS) has driven the development of precision oncology. While adult cancer genomics has been extensively studied, pediatric cancer, particularly among Asian populations, has received less attention. Methods: We screened gene alteration profiles of 99 pediatric cancer patients using the targeted NGS panel and compared the results with those from Western cohorts. The relationship between genes and clinical characteristics was also analyzed.  \nResults: The most frequently mutated gene was KMT2D (18.2%), followed by TP53 (11.1%) and DICER1 (9.1%). The frequency of KMT2D mutations in our cohort is significantly higher than in Western cohorts, whereas TP53 mutations showed no significant difference. Pathogenic or likely pathogenic (P/LP) germline mutations were identified in only 3.5% of the patients. Notably, 69%-75% of patients had at least one genomic alteration with potential clinical significance. In neuroblastoma (NB), the most commonly altered genes were MYCN (7/48), DICER1 (6/48), ARID1B, EGFR, KMT2D, and TCF3 (5/48). In a subset of intermediate-/ high-risk NB patients (n = 33), MYCN amplification was associated with disease progression during induction chemotherapy, and gene alterations in the MAPK pathway were associated with poor survival. We also identified novel alterations in specific tumor types, including SFPQ-TACC1 fusion in NB.  \nConclusions: Our findings enhance understanding of the genomic landscape of Chinese pediatric cancer populations. Further research is required to validate these findings and fully explore the potential of genomic data to improve outcomes for pediatric cancer patients.  \nKey words: pediatric cancer; KMT2D; neuroblastoma; NGS  \nImplications for Practice  \nPediatric cancer genomics remains underexplored, particularly in Asian populations. This study retrospectively analyzed genomic alterations in Chinese pediatric cancer patients, compared the results with those of Western cohorts, and explored the relationship between mutations and neuroblastoma prognosis. These findings may inform the development of precision medicine strategies, enhancing treatment decisions, prognostic predictions, and personalized therapies for pediatric cancer patients.  \nReceived: October 17, 2025. Accepted: April 13, 2026 © The Author(s) 2026. Published by Oxford University Press.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact ","cbCairzQibOJYWKF","https://ap.wps.com/l/cbCairzQibOJYWKF","pdf",1811666,12,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Implications for Practice\n# Introduction\n# Methods and Study Design (implied by Abstract)","[{\"question\":\"What method was used to detect gene alterations in this study?\",\"answer\":\"Targeted next generation sequencing (NGS) was used to screen gene alteration profiles in 99 pediatric cancer patients.\"},{\"question\":\"Which genes were most frequently mutated in the cohort?\",\"answer\":\"KMT2D was the most frequently mutated gene (18.2%), followed by TP53 (11.1%) and DICER1 (9.1%).\"},{\"question\":\"What prognostic associations were reported for neuroblastoma?\",\"answer\":\"For intermediate-/high-risk neuroblastoma patients, MYCN amplification was associated with disease progression during induction chemotherapy, and gene alterations in the MAPK pathway were linked to poor survival.\"}]","Next generation sequencing identifies novel gene alterations with potential prognostic relevance in pediatric cancer - a single-center study | PDF",1790108874,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7692a00127d651a262b86a49f2cfd869.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9991e8678754a10f327a0716d8e2819.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a83876a49ed8b13cfcc9b81cb00a1251.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/022d7001a5829770b1b90c80380f7ddc.webp",980,1287]